Prolonged Support Using a Percutaneous OxyRVAD in a Patient with End-Stage Lung Disease, Pulmonary Hypertension, and Right Cardiac Failure

ASAIO Journal : a Peer-reviewed Journal of the American Society for Artificial Internal Organs
Christian A BermudezMaria M Crespo

Abstract

Options for cardiopulmonary support in patients with severe pulmonary hypertension (PH) that is not associated with left-sided heart failure are limited. We describe the novel use of prolonged percutaneous venovenous extracorporeal membrane oxygenation as a right ventricular assist device in a patient presenting with cardiogenic shock because of severe PH decompensation.

References

Apr 1, 2008·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Igor D GregoricBiswajit Kar
Aug 25, 2010·The Annals of Thoracic Surgery·Christian A BermudezArthur J Boujoukos
May 10, 2011·The Annals of Thoracic Surgery·Theodosios BisdasOmke E Teebken
Dec 5, 2013·ASAIO Journal : a Peer-reviewed Journal of the American Society for Artificial Internal Organs·Erika B RosenzweigMatthew Bacchetta
Feb 3, 2015·The Annals of Thoracic Surgery·Nikhil Prakash PatilAndre R Simon

❮ Previous
Next ❯

Citations

Jul 19, 2017·Circulation·Navin K KapurDaniel Burkhoff
Nov 7, 2019·Journal of Cardiac Surgery·Ilija DjordjevicThorsten Wahlers
Feb 25, 2020·Expert Review of Respiratory Medicine·Soo Jin Na, Kyeongman Jeon
Apr 8, 2020·Cardiac Failure Review·Federica JiritanoRoberto Lorusso
Feb 6, 2021·Clinics in Chest Medicine·Laura M PiechuraHari R Mallidi
Mar 23, 2021·Interventional Cardiology Clinics·Akbarshakh Akhmerov, Danny Ramzy

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiogenic Shock

Cardiogenic shock is a devastating consequence of acute myocardial infarction and is associated with an extremely high mortality. Here is the latest research.

Artificial Heart & Ventricular Assist Devices

Total artificial hearts (TAH) and ventricular assist devices (VADs) provide cardiac support for patients with end-stage heart disease and have significantly improved the survival of these patients. Discover the latest research on Artificial Heart and Ventricular Assist Devices here.